drugset / Trial / NCT01660867

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department

NCT01660867

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a prospective, randomized, controlled, double-blinded, clinical trial Subject : 3mo \~ 24mo. aged infants with bronchiolitis The effect of 3 % NaCl nebulizer or dexamethasone on admission rate of these infants in ED.

Timeline

Start
2012-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule Oral
Subject sodium chloride Unknown 0.9 % Inhaled
Subject sodium chloride Unknown 3 % Inhaled
Background Epinephrine Other / unclassified Inhaled

Indications